Inozyme Pharma

Filed a patent for "treatment of enpp1 deficiency and abcc6 deficiency in children" on Tue, August 22, 2023

Filed a patent for "treatment of diseases involving deficiency of enpp1 or enpp3" on Thu, February 2, 2023

Filed a patent for "compositions and methods for treating peripheral artery disease" on Thu, November 23, 2023

Filed a patent for "compositions and methods for inhibiting vascular smooth muscle cell proliferation" on Thu, October 19, 2023

Filed a patent for "soluble enpp1 proteins and uses thereof" on Thu, October 5, 2023

Filed a patent for "compositions and methods for treating allograft vasculopathy, moyamoya disease, moyamoya syndrome and intimal proliferation" on Thu, January 18, 2024

Filed a patent for "liver specific production of enpp1 or enpp3" on Thu, May 9, 2024

Filed a patent for "treatment of enpp1 deficiency and abcc6 deficiency" on Thu, June 6, 2024

Filed a patent for "methods of treating myointimal proliferation" on Thu, November 10, 2022